LambdaVision Books Commercial Space in Low-Earth Orbit with Starlab Space and Voyager Technologies

WOODBRIDGE, Conn.--(BUSINESS WIRE)--LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, is advancing its commercialization efforts by pre-booking commercial space in low-Earth orbit (LEO) through partnerships with Starlab Space LLC, a joint venture led by Voyager Technologies. This strategic agreement supports LambdaVision's plan to scale manufacturing of its protein-based artificial retina. ...